PHARMA-SKAN ApS: Financial statements 2025
CVR: 16275247
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
PHARMA-SKAN ApS (CVR 16275247) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 12,339,941 and a net result of DKK 7,875,190 compared with DKK 11,288,304 the year before. That is a decrease of 19.2% compared with the year before. Equity in the 2025 report amounted to DKK 8,543,005. The solvency ratio was 51%. The company had 15 employees in the financial year.
- Gross Profit
- DKK 12,339,941
- Profit/Loss
- DKK 7,875,190
- Equity
- DKK 8,543,005
- Total Assets
- DKK 16,759,365
- Employees
- 15
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 12.3 mio. | 7.9 mio. | 8.5 mio. | 15 |
| 2024 | - | 15.3 mio. | 11.3 mio. | 19.2 mio. | 13 |
| 2023 | - | 15.3 mio. | 11.5 mio. | 19.9 mio. | 14 |
| 2022 | - | 14.8 mio. | 10.9 mio. | 18.9 mio. | 13 |
| 2021 | - | 12.4 mio. | 9.1 mio. | 17 mio. | 13 |
Official annual report
How creditworthy is PHARMA-SKAN ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of March 31, 2025, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of PHARMA-SKAN ApS.
As of March 31, 2025, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of PHARMA-SKAN ApS.
As of March 31, 2025, Jan Dam has joined the board of directors of PHARMA-SKAN ApS.
As of March 31, 2025, Kent Ernst Hansen has joined the board of directors of PHARMA-SKAN ApS.
As of March 31, 2025, Line Wulff has joined the board of directors of PHARMA-SKAN ApS.
As of March 31, 2025, Ib Gunnar Christensen is registered as director of PHARMA-SKAN ApS.
As of March 31, 2025, Line Wulff is registered as adm. dir. of PHARMA-SKAN ApS.
As of March 31, 2025, Susanne Rasmussen has stepped down as director of PHARMA-SKAN ApS.
As of March 30, 2025, Ib Gunnar Christensen has stepped down as director of PHARMA-SKAN ApS.
PHARMA-SKAN ApS has published its annual report for 2024. Gross profit came to DKK 15,271,780, and the net result was DKK 11,288,304.
About PHARMA-SKAN ApS
PHARMA-SKAN ApS is a Danish company of the type Anpartsselskab based in Skanderborg, founded in 1992. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named ApS KBUS 38 NR. 2587. The management consists of Line Wulff and Ib Gunnar Christensen. The board consists of Jan Dam (chair), Kent Ernst Hansen, Lars Enghave Minor and Line Wulff. The company is owned by BESULA ApS. The company has 19 employees (2026). In 2025, the company reported a gross profit of DKK 12,339,941 and a net result of DKK 7,875,190 compared with DKK 11,288,304 the year before. Equity in the 2025 report amounted to DKK 8,543,005.